John Lee
Family Medicine · Forest, MSNPI 1992806699
Payments from drug & device makers
Across 311 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$846
- GSK$518
- Novo Nordisk$468
- AbbVie$382
- Novartis$262
- Abbott$247
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,598100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 56 | $846 |
| GSK | 37 | $518 |
| Novo Nordisk | 26 | $468 |
| AbbVie(2 entities) | 30 | $382 |
| Novartis | 15 | $262 |
| Abbott | 17 | $247 |
| Boehringer Ingelheim | 26 | $246 |
| Amgen | 13 | $237 |
| Lilly USA, LLC | 13 | $202 |
| Astellas Pharma US Inc | 11 | $173 |
| Merck | 11 | $167 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $148 |
| Johnson & Johnson | 12 | $146 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $87 |
| Sunovion Pharmaceuticals Inc. | 4 | $77 |
| Biogen | 4 | $69 |
| Pfizer | 5 | $63 |
| Sanofi-aventis U.S. LLC | 4 | $62 |
| Bayer | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Inari Medical, Inc. | 2 | $28 |
| Lundbeck LLC | 1 | $22 |
| Sun Pharmaceutical Industries Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Inspire Medical Systems, Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $13 |
| Corium, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$122
How this compares
$4,598 in reported general payments places this provider in the 80th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 115 | $114,917 |
| EliquisApixaban | 136 | $96,614 |
| JardianceEmpagliflozin | 107 | $96,265 |
| RybelsusSemaglutide | 50 | $79,742 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 93 | $73,974 |
| OzempicSemaglutide | 72 | $68,484 |
| XareltoRivaroxaban | 36 | $33,008 |
| MyrbetriqMirabegron | 28 | $26,679 |
| TrulicityDulaglutide | 22 | $23,033 |
| LinzessLinaclotide | 26 | $22,547 |
| JanuviaSitagliptin Phosphate | 21 | $19,491 |
| EntrestoSacubitril/Valsartan | 15 | $16,164 |
| TradjentaLinagliptin | 19 | $14,139 |
| BrilintaTicagrelor | 16 | $11,494 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 25 | $11,120 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskRybelsus, Ozempic | $468 | $148,226122 claims |
| AstraZenecaFarxiga, Brilinta, Symbicort | $846 | $132,144144 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $246 | $119,517138 claims |
| PfizerEliquis | $63 | $96,614136 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $518 | $78,127104 claims |
| Johnson & JohnsonXarelto | $146 | $33,00836 claims |
| Astellas Pharma US IncMyrbetriq | $173 | $26,67928 claims |
| Lilly USA, LLCTrulicity | $202 | $23,03322 claims |
| AbbVieLinzess | $382 | $22,54726 claims |
| MerckJanuvia | $167 | $19,49121 claims |
| NovartisEntresto | $262 | $16,16415 claims |
| Sanofi-aventis U.S. LLCLantus | $62 | $4,73422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Forest
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.